home / stock / slgl / slgl news


SLGL News and Press, Sol-Gel Technologies Ltd. From 05/23/25

Stock Information

Company Name: Sol-Gel Technologies Ltd.
Stock Symbol: SLGL
Market: NASDAQ
Website: sol-gel.com

Menu

SLGL SLGL Quote SLGL Short SLGL News SLGL Articles SLGL Message Board
Get SLGL Alerts

News, Short Squeeze, Breakout and More Instantly...

SLGL - Sol-Gel Technologies reports Q1 results

2025-05-23 10:28:31 ET More on Sol-Gel Technologies Financial information for Sol-Gel Technologies Read the full article on Seeking Alpha For further details see: Sol-Gel Technologies reports Q1 results

SLGL - Sol-Gel Reports First Quarter 2025 Results

NESS ZIONA, Israel, May 23, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd . (NASDAQ: SLGL), a clinical-stage dermatology company, today announced financial results for the first quarter ended March 31, 2025. Financial Results for the First Quarter Year Ended March ...

SLGL - Expected US Company Earnings on Monday, May 19th, 2025

Global Ship Lease Inc New Class A (GSL) is expected to report $2.27 for Q1 2025 Biolase Inc. (BIOLQ) is expected to report for quarter end 2025-03-31 ViewBix Inc (VBIXD) is expected to report for Q1 2025 8x8 Inc (EGHT) is expected to report $0.01 for Q4 2025 Gaucho Group Hol (VINO...

SLGL - SLGL announced stock split 1-10

2025-05-05 09:00:28 ET Sol-Gel Technologies Ltd. (SLGL) announced stock split at a ratio of 1-for-10 on 2025-05-05 ... Full story available on KlickAnalytics.com

SLGL - Sol-Gel Technologies to implement reverse stock split

2025-05-01 07:32:29 ET More on Sol-Gel Technologies Financial information for Sol-Gel Technologies Read the full article on Seeking Alpha For further details see: Sol-Gel Technologies to implement reverse stock split

SLGL - Sol-Gel Announces Reverse Share Split

NESS ZIONA, Israel, May 01, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (the “Company”) (NASDAQ: SLGL), a clinical-stage dermatology company, today announced a reverse share split (the “Reverse Split”) of the Company’s issued and outstanding ordinary shar...

SLGL - Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.

Sol-Gel to receive $16 million during 2025 Cash runway is expected to extend into the first quarter of 2027; Company expects to have sufficient cash to complete its Phase III clinical trial SGT-610 Phase III clinical trial top-line results are expected in the fourth quarter of 2026; a sig...

SLGL - Expected US Company Earnings on Wednesday, April 2nd, 2025

Global Gas Corporation (HGAS) is expected to report for Q4 2024 ABVC BioPharma Inc. (ABVC) is expected to report for quarter end 2024-12-31 Medalist Diversified REIT Inc. (MDRR) is expected to report for quarter end 2024-12-31 Healthier Choices Management Corp (HCMC) is expected to re...

SLGL - SLGL - Historical Earnings Price Analysis

2025-04-01 18:44:30 ET Sol-Gel Technologies Ltd. (SLGL) earnings is schedule to release on 2025-04-02. Following Earnnigs Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in SLGL stock price following earnings has ...

SLGL - Expected US Company Earnings on Wednesday, March 26th, 2025

Nu Ride Inc. - Class A (NRDE) is expected to report for quarter end 2024-12-31 Dalrada Financial Corp. (DFCO) is expected to report for quarter end 2024-12-31 HilleVax Inc. (HLVX) is expected to report $-0.38 for Q4 2024 Chewy Inc. Class A (CHWY) is expected to report $0.03 for Q4 202...

Previous 10 Next 10